What's Happening?
The New Mexico Environment Department (NMED) has outlined proposed actions for the 2027 legislative session aimed at strengthening the Per- and Polyfluoroalkyl Substances (PFAS) Protection Act. During a presentation to the New Mexico legislature’s Radioactive
and Hazardous Materials Committee on November 5, 2026, NMED Secretary James C. Kenney suggested sunsetting exemptions in the current Act and accelerating the phaseout schedule for PFAS-containing products. The current Act, enacted in April 2025, exempts several products from prohibition and reporting requirements, including medical devices regulated by the U.S. Food and Drug Administration (FDA) and veterinary products under the jurisdiction of the USDA or EPA. NMED has reopened its public comment portal for its House Joint Memorial (HJM) 3 report until December 31, 2026, which addresses the efficacy of rules promulgated by the Environmental Improvement Board (EIB) and the risks of current exemptions.
Why It's Important?
NMED's proposals have significant implications for industries operating in New Mexico and for consumer safety. If adopted, sunsetting exemptions and accelerating the phaseout of PFAS could lead to stricter regulations for manufacturers of a wide range of products, from electronics to medical devices. This could necessitate costly reformulations, supply chain adjustments, and potentially impact product availability. For consumers, these changes aim to reduce exposure to PFAS, which have been linked to various health risks, including certain types of breast cancer. The debate also highlights the challenge of balancing environmental protection with economic considerations, as industries argue for the safety of certain PFAS applications and the difficulty of finding viable alternatives.
What's Next?
Manufacturers and stakeholders are urged to provide information supporting the safety of PFAS used in their products and to identify viable alternatives by December 31, 2026, during the public comment period for NMED's HJM 3 report. NMED is conducting literature reviews to assess the public health, environmental, and economic risks associated with the current exemptions. The 2027 legislative session will likely see proposals to require reporting for exempt products, accelerate the PFAS phaseout schedule, sunset existing exemptions, and explicitly state NMED's authority to assess and collect fees. The outcome will shape the regulatory landscape for PFAS in New Mexico, potentially setting a precedent for other states.
Beyond the Headlines
The push to strengthen New Mexico's PFAS Protection Act reflects a growing national concern over 'forever chemicals' and their pervasive presence in consumer products and the environment. The discussion around sunsetting exemptions and accelerating phaseouts delves into complex scientific and economic considerations, as not all PFAS have the same risk profile, and viable alternatives are not always readily available. This situation underscores the broader challenge of regulating emerging contaminants, where scientific understanding is continually evolving, and policy decisions must balance precautionary principles with practical industry constraints. The legal challenges to current regulations, such as the one brought by Diamond Vogel, Inc. regarding labeling requirements and fees, further complicate the regulatory environment, highlighting the need for clear and legally defensible policies.













